Soleno Therapeutics's total assets for Q3 2024 were $296.71M, a decrease of -2.44% from the previous quarter. SLNO total liabilities were $32.01M for the fiscal quarter, a 36.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.